Recently, the presence of tumor-infiltrating lymphocytes (TILs) expressing PD-1 in HCC tumors suggests that immunotherapy with ICIs might be helpful in the treatment of HCC [96]. Here, PDCD1 is linked to hepatocellular carcinoma.